Chronic Somogyi rebound
A phenomenon in diabetes management
Classification |
|
---|---|
External resources |
|
Overview[edit | edit source]
The Chronic Somogyi rebound, also known as the Somogyi effect, is a phenomenon observed in individuals with diabetes mellitus, particularly those who are insulin-dependent. It is characterized by a pattern of hypoglycemia followed by rebound hyperglycemia. This effect is named after Dr. Michael Somogyi, a Hungarian-born American biochemist who first described the phenomenon.
Pathophysiology[edit | edit source]
The Somogyi effect occurs when an excessive dose of insulin causes a drop in blood glucose levels during the night, leading to hypoglycemia. In response to this low blood sugar, the body releases counterregulatory hormones such as glucagon, epinephrine, cortisol, and growth hormone. These hormones stimulate gluconeogenesis and glycogenolysis, resulting in an increase in blood glucose levels, or hyperglycemia, by the morning.
Clinical Presentation[edit | edit source]
Patients experiencing the Somogyi effect may report symptoms of nocturnal hypoglycemia, such as night sweats, nightmares, or restless sleep. Upon waking, they may experience symptoms of hyperglycemia, including fatigue, headache, and blurred vision.
Diagnosis[edit | edit source]
Diagnosing the Somogyi effect involves monitoring blood glucose levels throughout the night. Patients are advised to check their blood sugar at bedtime, during the night (typically around 2-3 AM), and upon waking. A pattern of low blood sugar during the night followed by high blood sugar in the morning suggests the presence of the Somogyi effect.
Management[edit | edit source]
Management of the Somogyi effect involves adjusting the insulin regimen to prevent nocturnal hypoglycemia. This may include reducing the dose of long-acting insulin or changing the timing of insulin administration. Patients are also advised to have a bedtime snack to help maintain stable blood glucose levels overnight.
Related pages[edit | edit source]
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD's Wellness Encyclopedia |
Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD